In line with this, lncRNA H19 is found to be highly enriched in breast cancer cell lines and tumor tissues that are resistant to tamoxifen, and H19 knockdown in tamoxifen-resistant models results in a resensitization to tamoxifen [133]. This evidence concerns the gene H19 and breast carcinoma.